The enrollment goal was achieved in one month
WCR met its site enrollment goal within one month for this Phase 3 study in moderate-to-severe atopic dermatitis.
Phase 3 · Moderate-to-severe atopic dermatitis
Enrollment goal met in one month. 100% study completion.
WCR reached its enrollment goal in one month for a Phase 3 moderate-to-severe atopic dermatitis study. Thirty percent of randomized participants were ages 12-17, and every enrolled participant completed the trial.
Explore the study storyStudy outcome
100%of enrolled participants completed the trial1month to meet enrollment goal
30%of randomized participants were ages 12-17
100%study completion
Inside the case
Every enrolled participant completed the trial
Following enrollment, all participants completed the study. The 100% completion rate captures the full participation outcome across the trial follow-up period.
Pediatric participation within the study
Thirty percent of randomized participants were ages 12-17, demonstrating WCR’s experience engaging adolescents alongside the broader study population. All enrolled participants completed the trial.
Delivery from enrollment through completion
Our team maintained participant relationships beyond enrollment, with open communication throughout follow-up. Participants demonstrated high compliance with study requirements, and every enrolled participant completed the trial.
The challenge. Our response.
A demanding diary. Frequent visits. A prepared participant.
Restrictive eligibility, demanding diary requirements, and frequent on-site visits required sustained engagement. Thirty percent of randomized participants were ages 12-17.
Restrictive eligibility
The challenge
Potential participants needed to meet the protocol’s eligibility requirements before entering the study.
How our team responds
We use focused pre-screening to review potential eligibility and discuss the full participation commitment before screening, bringing qualification and readiness into the same conversation.
Demanding diary requirements
The challenge
Diary completion required ongoing attention between visits, including from adolescent participants.
How our team responds
We explain diary expectations clearly before enrollment and keep communication open throughout participation so questions or difficulties can be raised early. For adolescents, our approach includes clear communication with participants and their caregivers.
Frequent on-site visits
The challenge
The study required many on-site visits, adding repeated scheduling and travel demands for participants and families.
How our team responds
We discuss the visit commitment early, plan appointments around availability within protocol requirements, and stay connected when scheduling concerns arise. Transportation support is available when needed.
Study outcome
Enrollment goal achieved in one month. Every enrolled participant completed the trial.
The participant experience
Meet the goal. Keep the relationship going.
Our team set expectations before screening and continued building relationships throughout follow-up, including with adolescent participants and caregivers. Open communication supported high compliance with study requirements. Thirty percent of randomized participants were ages 12-17, and every enrolled participant completed the trial.
Set expectations before screening
We discuss the study commitment early, including what participation will require and whether candidates feel ready to meet those expectations. Pre-screening helps establish a shared understanding before the first screening visit.
Build a working relationship
Participants need a team they can talk to. We build relationships throughout the study and keep communication open so questions and practical concerns can be raised with the site.
Keep the focus on follow-through
Our participant engagement approach continues beyond randomization. We stay connected throughout participation to support retention and compliance with study requirements.
Practical participant support
Help with the journey.
Support through the study.
We provide transportation support when needed to help participants attend study visits. We also discuss scheduling concerns early and maintain open communication throughout participation, helping address the practical barriers that can make follow-through difficult.
The result
Enrollment goal achieved in one month. Every enrolled participant completed the trial.
Phase 3 · Moderate-to-severe atopic dermatitis · WCR case study
Your next study
Build your next study
on a stronger start.
Talk with our Miami Lakes and Puerto Rico teams about your protocol, patient population, and the participation demands that matter to your study.